Anita H.
- Country
- Hungary
- Department
- Bőr-, Nemikórtani és Onkodermatológiai Klinika
Research Overview
- Long-Term Safety and Efficacy Evaluation of Litifilimab (BIIB059) in Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus
- Efficacy and Safety Evaluation of Litifilimab in Active Subacute and Chronic Cutaneous Lupus Erythematosus Refractory to Antimalarial Therapy
- A global, multicenter, randomized, double-blind, double-dummy, parallel-group, Phase 3b study to assess the efficacy, safety, and tolerability of remibrutinib 25 mg b.i.d. in comparison to placebo with omalizumab 300 mg every 4 weeks as active control over 52 weeks in adult patients with chronic spontaneous urticaria inadequately controlled by second-generation H1-antihistamines and an open-label 52-week optional extension to assess long-term efficacy, safety and tolerability of remibrutinib 25 mg b.i.d.
Data & Insights
Has run more than one trial at 62 of 155 partner sites.
Specializations
Autoimmune Skin Disorders
The investigator specializes in treating complex cutaneous lupus erythematosus, including both subacute and chronic forms. Their research encompasses therapeutic approaches for patients who show inadequate response to conventional antimalarial treatments.
- Subacute Cutaneous Lupus Erythematosus (SCLE)
- Chronic Cutaneous Lupus Erythematosus (CCLE)
Expertise includes evaluation of novel biological therapies for managing lupus-related skin manifestations.
Chronic Urticaria Management
Focuses on advanced treatment options for chronic spontaneous urticaria, particularly in cases where standard antihistamine treatments prove insufficient. The investigator evaluates innovative therapeutic approaches targeting specific immune pathways.
- Antihistamine-Refractory Urticaria
- Novel Therapeutic Compounds
Specializes in long-term management strategies for persistent urticaria symptoms.
Bullous Skin Conditions
Conducts research in the treatment of bullous pemphigoid, investigating subcutaneous therapeutic options. The investigator's work focuses on achieving sustained disease remission through targeted immunological interventions.
- Autoimmune Blistering Diseases
- Immunological Therapy Development
Explores innovative approaches for managing chronic autoimmune skin conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.